Transforming Global Genetic Data into Medical Decisions
THE RARE DISEASE COMPANY
We harness the power of multiomics and advanced technology to resolve the mysteries of rare genetic diseases. By leveraging unparalleled levels of unique data, we create never-before-seen insights into the complexities of individual rare diseases and accelerate targeted treatment options.
By working together with patients, physicians, and partners, we lead clinical studies and global research to advance diagnostic technologies and accelerate orphan drug development.
WHAT WE DO
Connect Patients Around the World
Our unique assets continue to deliver answers and solutions. CENTOGENE’ s rare disease mutation database, CentoMD®, combines insights of nearly 600,000 patients from over 120 countries to deliver inarguable results – both in diagnostics and orphan drug development.
Diagnose. Understand. Treat.
Millions of dollars and decades of time can be saved by approaching orphan drug development with innovation and rationality.
Innovate and Simplify
At CENTOGENE, we are more than just a company, we are a culture. We breathe, sleep, and live for innovation. Through simplification, we succeed. We push the limits on what ‘once was,’ and the outcome: we drive solutions that save lives.